Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma

Published:2015-08-08 Issue:4 Volume:34 Page:561-567
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Cai Chen,Xu Yi-Fan,Wu Zhen-Jie,Dong Qin,Li Min-Yu,Olson Jason C.,Rabinowitz Yaron M.,Wang Lin-Hui,Sun Yinghao

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-015-1656-7.pdf

Reference22 articles.

1. Ljungberg B (2013) The role of metastasectomy in renal cell carcinoma in the era of targeted therapy. Curr Urol Rep 14:19–25

2. Sircar K, Rao P, Jonasch E, Monzon FA, Tamboli P (2013) Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features. Chin J Cancer 32:303–311

3. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H et al (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536–541

4. Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX et al (2003) Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4:1093–1101

5. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sanchez-Fueyo A et al (2003) Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4:1102–1110

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model;Frontiers in Immunology;2024-05-24

2. Immune checkpoint inhibitors associated cardiovascular immune-related adverse events;Frontiers in Immunology;2024-02-05

3. Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma;Cells;2023-12-22

4. Immunobiology and Metabolic Pathways of Renal Cell Carcinoma;Hematology/Oncology Clinics of North America;2023-10

5. Emerging resistance vs. losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena;Cancer Drug Resistance;2023-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3